Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,591,495
-$341,869 QoQ
Shares Held
66,092
-4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#1,067
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLC Capital Advisors holds $21,615,806 across 11 Drug Manufacturers - General names. PFE ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
86,579 | $11,125,401 | |
| 2 | JNJ |
Johnson & Johnson
|
13,403 | $3,403,959 | |
| 3 | PFE |
Pfizer Inc
This page
|
66,092 | $1,591,495 | |
| 4 | ABBV |
AbbVie Inc.
|
6,063 | $1,525,693 | |
| 5 | LLY |
ELI LILLY & Co
|
1,111 | $1,332,566 | |
| 6 | AMGN |
Amgen Inc
|
2,086 | $755,382 | |
| 7 | NVS |
Novartis AG
|
3,066 | $480,503 | |
| 8 | NVO |
Novo Nordisk A S
|
9,824 | $470,962 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,591,495 | 66,092 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,933,364 | 68,852 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,755,101 | 70,486 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,828,113 | 71,747 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,398,454 | 57,692 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,482,136 | 58,490 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,263,119 | 47,611 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,122,061 | 38,772 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $929,383 | 33,216 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,017,481 | 36,666 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $988,936 | 34,350 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,567,514 | 47,257 | Shares | Sole | 2024-01-18 | |
| 2023-06-30 | $2,006,212 | 54,695 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,386,922 | 58,503 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $3,176,111 | 61,985 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $2,798,802 | 63,958 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $3,511,656 | 66,978 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,557,841 | 68,724 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $4,158,064 | 70,416 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $3,089,623 | 71,835 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $2,902,382 | 74,116 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,688,519 | 74,207 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,193,029 | 59,577 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,830,814 | 49,886 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $1,325,626 | 40,539 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $1,112,565 | 34,086 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||